Bill Sibold, Madrigal Pharmaceuticals CEO
Madrigal 'encouraged' by early launch progress of landmark NASH drug
Madrigal Pharmaceuticals is “making great progress” on the rollout of its NASH drug Rezdiffra, executives said less than a month post-launch.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
